Learn More
Cayman Chemical NLG-919 nalog 10mg

Supplier: Cayman Chemical 2150910 MG
An inhibitor of IDO1 and TDO (IC50s = 79 and 25 nM, respectively, in cell-free assays); decreases kynurenine levels in cells expressing human IDO1 (EC50 = 83 nM); decreases the percentage of PD-1+ anti-CD3- and anti-CD28-activated Jurkat T cells from 0.025-1 µM; decreases tumor volume and weight and the percentage of intratumoral CD4+CD25+ Tregs in a B16/F10 murine melanoma model at 100 mg/kg when administered alone or in combination with paclitaxel
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.